Retractable Technologies (RVP) Non-Current Assets (2010 - 2026)
Retractable Technologies' (RVP) quarterly Non-Current Assets came in at $75.8 million in Q2 2026, down 9.9% on a YoY basis from $84.1 million in Q2 2025, and down 2.4% quarter-over-quarter from $77.6 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Non-Current Assets (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Non-Current Assets for 17 consecutive years, with $75.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 9.9% year-over-year to $75.8 million; the trailing twelve-month figure through Jun 2026 stood at $315.3 million (down 8.95% YoY), and the FY2025 full-year result was $79.5 million, down 9.04% from the prior year.
- Non-Current Assets retreated to $75.8 million in Q2 2026 per RVP's latest filing, from $77.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $108.8 million in Q3 2022 and bottomed at $75.8 million in Q2 2026.
- Historically, Non-Current Assets has averaged $93.9 million across 5 years, with a median of $95.2 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 103.55% in 2022, then dropped 14.58% in 2025.
- Over 5 years, Non-Current Assets stood at $106.9 million in 2022, then slipped by 4.52% to $102.0 million in 2023, then retreated by 14.28% to $87.5 million in 2024, then retreated by 9.04% to $79.5 million in 2025, then slipped by 4.75% to $75.8 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $75.8 million, $77.6 million, and $79.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 42.59 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 27.61 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 2.27 Bn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 12.80 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | - |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 88.31 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 20.17 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 75.77 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 183,321.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | 1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.77 Mn |
| Mar 31, 2026 | 77.64 Mn |
| Dec 31, 2025 | 79.55 Mn |
| Sep 30, 2025 | 82.31 Mn |
| Jun 30, 2025 | 84.09 Mn |
| Mar 31, 2025 | 85.65 Mn |
| Dec 31, 2024 | 87.45 Mn |
| Sep 30, 2024 | 89.05 Mn |
| Jun 30, 2024 | 90.18 Mn |
| Mar 31, 2024 | 100.26 Mn |
| Dec 31, 2023 | 102.02 Mn |
| Sep 30, 2023 | 103.72 Mn |
| Jun 30, 2023 | 104.21 Mn |
| Mar 31, 2023 | 105.14 Mn |
| Dec 31, 2022 | 106.86 Mn |
| Sep 30, 2022 | 108.80 Mn |
| Jun 30, 2022 | 106.34 Mn |
| Mar 31, 2022 | 101.00 Mn |
| Dec 31, 2021 | 101.80 Mn |
| Sep 30, 2021 | 89.78 Mn |